Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised the arrangers in connection with Heimstaden’s EUR 350,000,000 bond issuance
Mandate

Vinge has advised the arrangers in connection with Heimstaden’s EUR 350,000,000 bond issuance

March 09, 2021 Banking and Finance Capital Markets and Public M&A

The banks acted as arrangers and bookrunners in connection with Heimstaden AB’s (publ) issuance of EUR 350,000,000 senior unsecured bonds, within a framework amount of EUR 450,000,000.

The bond proceeds are intended to be used for the purchase of equity in Heimstaden Bostad AB and general corporate purposes. In accordance with the terms and conditions, the bonds are intended to be listed on the corporate bond list of Nasdaq Stockholm.

Vinge’s team consisted of Louise Brorsson Salomon and Lionardo Ojeda (Banking and Finance) together with Jesper Schönbeck and Linnéa Sellström (Capital Markets and Public M&A).

Related

Vinge advises OsteoCentric on the public offer for Integrum

 OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

 Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025